Manipal Health Enterprises Delivers Strong Q2 FY27 Revenue and Operational Growth
Manipal Health Enterprises Ltd · Investor Presentation · 13 Nov 2026, 9:53 pm
Manipal Health Enterprises Delivers Strong Q2 FY27 Revenue and Operational Growth Manipal Health Enterprises reported a 37.3% YoY rise in Q2 FY27 revenue from operations to ₹3,399.4 crore, with EBITDA climbing 29.8% YoY to ₹882.2 crore at a 26.0% margin. Adjusted PAT (excluding exceptional items) increased 21.6% YoY to ₹380.2 crore, and rose 45.6% YoY to ₹455 crore excluding post-tax Sahyadri acquisition NCD interest. Inpatient volumes grew 35.0% to ~169,000, while occupancy improved 160 bps YoY to 70.1%. Ex-Sahyadri ARPOB rose 8.5% YoY to ₹76,600 per day. Net debt stood low at ₹343 crore.
Original exchange filing (PDF)
More announcements from Manipal Health Enterprises Ltd
- Transcript of the Earnings call with Analysts/Investor · 16 Nov 2026
- Manipal Health Enterprises Limited has informed the exchange about Audio Recording of the Earnings call with Analysts/ Investor · 14 Nov 2026
- Completion of acquisition of Kinder Women''s Hospital and Fertility Centre · 14 Nov 2026
- Monitoring Agency Report · 14 Nov 2026
- Press Release and Investor Presentation in relation to unaudited financial results for quarter and half year ended 30.09.2026. · 13 Nov 2026
- Approval of unaudited financial results for quarter and half year ended 30.09.2026 · 13 Nov 2026
- Approval of unaudited financial results for quarter and half year ended 30.09.2026 · 13 Nov 2026
- Manipal Health Enterprises Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
